162 related articles for article (PubMed ID: 28775780)
1. Treatment of Neuroblastoma with an Engineered "Obligate" Anaerobic
Ning BT; Yu B; Chan S; Chan JL; Huang JD; Chan GC
J Cancer; 2017; 8(9):1609-1618. PubMed ID: 28775780
[No Abstract] [Full Text] [Related]
2. Genetically modified "obligate" anaerobic Salmonella typhimurium as a therapeutic strategy for neuroblastoma.
Guo ZL; Yu B; Ning BT; Chan S; Lin QB; Li JC; Huang JD; Chan GC
J Hematol Oncol; 2015 Aug; 8():99. PubMed ID: 26286454
[TBL] [Abstract][Full Text] [Related]
3. 'Obligate' anaerobic
Li CX; Yu B; Shi L; Geng W; Lin QB; Ling CC; Yang M; Ng KT; Huang JD; Man K
Oncol Lett; 2017 Jan; 13(1):177-183. PubMed ID: 28123538
[TBL] [Abstract][Full Text] [Related]
4. Obligate anaerobic
Yu B; Shi L; Zhang BZ; Zhang KE; Peng X; Niu HB; Qu JL
Oncol Lett; 2015 Aug; 10(2):1069-1074. PubMed ID: 26622627
[TBL] [Abstract][Full Text] [Related]
5. Explicit hypoxia targeting with tumor suppression by creating an "obligate" anaerobic Salmonella Typhimurium strain.
Yu B; Yang M; Shi L; Yao Y; Jiang Q; Li X; Tang LH; Zheng BJ; Yuen KY; Smith DK; Song E; Huang JD
Sci Rep; 2012; 2():436. PubMed ID: 22666539
[TBL] [Abstract][Full Text] [Related]
6. Nanophotosensitizer-engineered Salmonella bacteria with hypoxia targeting and photothermal-assisted mutual bioaccumulation for solid tumor therapy.
Chen F; Zang Z; Chen Z; Cui L; Chang Z; Ma A; Yin T; Liang R; Han Y; Wu Z; Zheng M; Liu C; Cai L
Biomaterials; 2019 Sep; 214():119226. PubMed ID: 31174068
[TBL] [Abstract][Full Text] [Related]
7. Targeted IFNγ induction by a genetically engineered
Hua Z; Wu S; Zhang Y; Wang X; Cui J; Li Y; Yang C; Zhai M; Deng B; Yu B; Huang JD; Wang Z; Zhou J
Front Med (Lausanne); 2023; 10():1284120. PubMed ID: 38020179
[TBL] [Abstract][Full Text] [Related]
8. Tumor Temporal Proteome Profiling Reveals the Immunological Triple Offensive Induced by Synthetic Anti-Cancer
Yang S; Zhao W; Zhu M; Hu H; Wang W; Zang Z; Jin M; Bi J; Huang J; Liu C; Li X; Yin P; Li N
Front Immunol; 2021; 12():712936. PubMed ID: 34489962
[TBL] [Abstract][Full Text] [Related]
9. Three-dimensional tumor spheroids for in vitro analysis of bacteria as gene delivery vectors in tumor therapy.
Osswald A; Sun Z; Grimm V; Ampem G; Riegel K; Westendorf AM; Sommergruber W; Otte K; Dürre P; Riedel CU
Microb Cell Fact; 2015 Dec; 14():199. PubMed ID: 26655167
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of YB1 C-terminal domain inhibits proliferation, angiogenesis and tumorigenicity in a SK-BR-3 breast cancer xenograft mouse model.
Shi JH; Cui NP; Wang S; Zhao MZ; Wang B; Wang YN; Chen BP
FEBS Open Bio; 2016 Jan; 6(1):33-42. PubMed ID: 27047740
[TBL] [Abstract][Full Text] [Related]
11. Tumor-targeting amino acid auxotrophic Salmonella typhimurium.
Hoffman RM
Amino Acids; 2009 Sep; 37(3):509-21. PubMed ID: 19291366
[TBL] [Abstract][Full Text] [Related]
12. Monotherapy with a tumor-targeting mutant of Salmonella typhimurium cures orthotopic metastatic mouse models of human prostate cancer.
Zhao M; Geller J; Ma H; Yang M; Penman S; Hoffman RM
Proc Natl Acad Sci U S A; 2007 Jun; 104(24):10170-4. PubMed ID: 17548809
[TBL] [Abstract][Full Text] [Related]
13. [Roles of Y box-binding protein 1 in SK-BR-3 breast cancer proliferation].
Shi J; Lü X; Wang B; Daudan L; Yanan W; Yuhui B; Zhenfeng M
Zhonghua Yi Xue Za Zhi; 2014 Sep; 94(36):2804-7. PubMed ID: 25534095
[TBL] [Abstract][Full Text] [Related]
14. Targeting liposomal chemotherapy via both tumor cell-specific and tumor vasculature-specific ligands potentiates therapeutic efficacy.
Pastorino F; Brignole C; Di Paolo D; Nico B; Pezzolo A; Marimpietri D; Pagnan G; Piccardi F; Cilli M; Longhi R; Ribatti D; Corti A; Allen TM; Ponzoni M
Cancer Res; 2006 Oct; 66(20):10073-82. PubMed ID: 17047071
[TBL] [Abstract][Full Text] [Related]
15. Targeted Cancer Therapy Using Engineered Salmonella typhimurium.
Zheng JH; Min JJ
Chonnam Med J; 2016 Sep; 52(3):173-84. PubMed ID: 27689027
[TBL] [Abstract][Full Text] [Related]
16. Targeted therapy with a Salmonella typhimurium leucine-arginine auxotroph cures orthotopic human breast tumors in nude mice.
Zhao M; Yang M; Ma H; Li X; Tan X; Li S; Yang Z; Hoffman RM
Cancer Res; 2006 Aug; 66(15):7647-52. PubMed ID: 16885365
[TBL] [Abstract][Full Text] [Related]
17. A phase I trial of genetically modified Salmonella typhimurium expressing cytosine deaminase (TAPET-CD, VNP20029) administered by intratumoral injection in combination with 5-fluorocytosine for patients with advanced or metastatic cancer. Protocol no: CL-017. Version: April 9, 2001.
Cunningham C; Nemunaitis J
Hum Gene Ther; 2001 Aug; 12(12):1594-6. PubMed ID: 11529249
[TBL] [Abstract][Full Text] [Related]
18. β-Carotene inhibits neuroblastoma cell invasion and metastasis in vitro and in vivo by decreasing level of hypoxia-inducible factor-1α.
Kim YS; Lee HA; Lim JY; Kim Y; Jung CH; Yoo SH; Kim Y
J Nutr Biochem; 2014 Jun; 25(6):655-64. PubMed ID: 24746828
[TBL] [Abstract][Full Text] [Related]
19. The novel thiosemicarbazone, di-2-pyridylketone 4-cyclohexyl-4-methyl-3-thiosemicarbazone (DpC), inhibits neuroblastoma growth in vitro and in vivo via multiple mechanisms.
Guo ZL; Richardson DR; Kalinowski DS; Kovacevic Z; Tan-Un KC; Chan GC
J Hematol Oncol; 2016 Sep; 9(1):98. PubMed ID: 27678372
[TBL] [Abstract][Full Text] [Related]
20. An obligatory anaerobic
Yang M; Xu J; Wang Q; Zhang AQ; Wang K
Oncol Lett; 2018 Mar; 15(3):3918-3922. PubMed ID: 29456740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
